Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1217023.RAiGBhUlArdQIqFFJyuGKBnmt5pLbl1qqVNYsxNT6Hv5Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1217023.RAiGBhUlArdQIqFFJyuGKBnmt5pLbl1qqVNYsxNT6Hv5Q130_assertion type Assertion NP1217023.RAiGBhUlArdQIqFFJyuGKBnmt5pLbl1qqVNYsxNT6Hv5Q130_head.
- NP1217023.RAiGBhUlArdQIqFFJyuGKBnmt5pLbl1qqVNYsxNT6Hv5Q130_assertion description "[Gene therapy for hematological disorders relies on the genetic modification of CD34(+) cells, a heterogeneous cell population containing about 0.01% long-term repopulating cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217023.RAiGBhUlArdQIqFFJyuGKBnmt5pLbl1qqVNYsxNT6Hv5Q130_provenance.
- NP1217023.RAiGBhUlArdQIqFFJyuGKBnmt5pLbl1qqVNYsxNT6Hv5Q130_assertion evidence source_evidence_literature NP1217023.RAiGBhUlArdQIqFFJyuGKBnmt5pLbl1qqVNYsxNT6Hv5Q130_provenance.
- NP1217023.RAiGBhUlArdQIqFFJyuGKBnmt5pLbl1qqVNYsxNT6Hv5Q130_assertion SIO_000772 25189742 NP1217023.RAiGBhUlArdQIqFFJyuGKBnmt5pLbl1qqVNYsxNT6Hv5Q130_provenance.
- NP1217023.RAiGBhUlArdQIqFFJyuGKBnmt5pLbl1qqVNYsxNT6Hv5Q130_assertion wasDerivedFrom befree-2016 NP1217023.RAiGBhUlArdQIqFFJyuGKBnmt5pLbl1qqVNYsxNT6Hv5Q130_provenance.
- NP1217023.RAiGBhUlArdQIqFFJyuGKBnmt5pLbl1qqVNYsxNT6Hv5Q130_assertion wasGeneratedBy ECO_0000203 NP1217023.RAiGBhUlArdQIqFFJyuGKBnmt5pLbl1qqVNYsxNT6Hv5Q130_provenance.